Currently, Dr. Weinshilboum serves as the Mary Low and John H. Dasburg Professor of Cancer Genomics, as well as the director for the division of clinical pharmacology at the Mayo Medical School.
Dr. Weinshilboum is a nationally recognized leader in the field of pharmacogenetics, the study of the role of inheritance in individual variations in drug response and in the occurrence of adverse drug reactions.
Dr. Weinshilboum’s laboratory studies the pharmacogenetics and pharmacogenomics of enzymes that catalyze the metabolism of drugs, other xenobiotics, neurotransmitters and hormones with a focus on drugs used to treat cancer and neuropsychiatric disease.
Dr. Weinshilboum received a bachelor of arts degree in chemistry and zoology from the University of Kansas, and a medical degree from the University of Kansas Medical School. He did his residency in internal medicine at Massachusetts General Hospital and completed fellowships at the NIH in the laboratory of Julius Axelrod and Tubingen University in Germany.
For more information on Dr. Weinshilboum’s research, visit http://mayoresearch.mayo.edu/mayo/research/staff/weinshilboum_rm.cfm .
For additional information, contact Natalie Kent at 461-1548.
